Industry News

As the first round of approved vaccines makes its’ way into arms around the world, scientists are still working tirelessly to find improved vaccines for years to come. One key avenue through which scientists are looking to make improvements is in the interactions between cells infected with SARS-CoV-2 and the human immune system. Studying these […]

To help tackle the difficulty of finding treatments for retinal diseases, Iveric Bio has established the “Gene Therapy Inherited Retina Disease Scientific Advisory Committee” to help translate research findings into actionable, clinical solutions. The committee is comprised of a specialized group of experts, all of whom focus in a specific niche. The committee is centrally involved with the gene […]

When Merck purchased OncoImmune to gain control of the experimental treatment for COVID-19, and shortly after signed a $356 million dollar government contract to deliver 100,000 doses by the summer, it was assumed that Merck would be able to deliver. However, despite positive trial data, the FDA is demanding that there be more evidence of the drug’s effect […]

Looking for new consulting work? Check out our open contractor positions at MVG: Manager of Clinical Quality Systems Clinical Quality Assurance Auditor Clinical Trial Manager Clinical Project Manager Medical Writer Contact MVG today with inquiries!

Heading towards the inevitable? COVID-19 paves the way for decentralized trials The pandemic has become a showcase for decentralized research that uses telemedicine and mobile tools to accelerate the pace of discovery. Source: How Covid-19 could drive a shift toward decentralized clinical trials

Technological innovation within the Pharmaceutical industry is on a clear path towards continued growth, and with that comes the opportunity for new players to get involved. Outside of speed and efficiency, the integration of technology also allows increased accessibility for companies perhaps not otherwise suited to infiltrate the industry. Virtual Pharma companies are a great […]

The speed with which COVID-19 vaccines are being developed leaves many uncertain about the safety and effectiveness of a potential vaccine. The global conference hosted by Harvard and MIT confronts this uncertainty and probes the question of how to evaluate and regulate drug development moving forward. Technology will play a central role in upcoming innovation, […]

When it comes to hiring the right talent to help a company succeed, the tradition has typically been to hire full-time talent that can be groomed to the culture and processes of a specific firm. However, investing in full time employees is costly, and doesn’t always ensure the productivity necessary to make that investment worthwhile. Thankfully, […]

COVID-19 has left a trail of uncertainty in its wake as the burden weighing on pharmaceutical companies working to get their clinical trials back on track appears somewhat insurmountable. These challenges facing the pharmaceutical industry are multifaceted as the number of trials previously put on hold now looking to reconvene is compounded by the growing […]

While the speedy development of a COVID-19 vaccine lends itself to a faster “return to normal”, the expedience raises some very legitimate concerns about the quality of such a rushed product. Due to the immense pressure to approve a vaccine quickly, a subpar and potentially dangerous vaccine may be on the fast track to approval […]